Update on Align AR Study

Saturday, March 8, 2025

9:36 AM – 9:44 AM ET

Speaker(s)

Vinod Thourani, MD, FACC, FACS

Professor of Surgery, Chairman of Cardiovascular Surgery
Piedmont Heart Institute
Atlanta, Georgia, United States

Disclosure(s): Abbott Labs: Consultant (Ongoing), Grant/Research Support (Ongoing); boston scientific: Grant/Research Support (Ongoing); Croivalve: Consultant (Ongoing), Grant/Research Support (Ongoing); DASI Simulations: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Edward Lifesciences: Consultant (Ongoing), Grant/Research Support (Ongoing); JenaValve Technology Inc: Consultant (Ongoing), Grant/Research Support (Ongoing); Laplace: Grant/Research Support (Ongoing); medtronic.: Grant/Research Support (Ongoing); trisol: Grant/Research Support (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Disclosure(s):

Vinod Thourani, MD, FACC, FACS: Abbott Labs: Consultant (Ongoing), Grant/Research Support (Ongoing); boston scientific: Grant/Research Support (Ongoing); Croivalve: Consultant (Ongoing), Grant/Research Support (Ongoing); DASI Simulations: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Edward Lifesciences: Consultant (Ongoing), Grant/Research Support (Ongoing); JenaValve Technology Inc: Consultant (Ongoing), Grant/Research Support (Ongoing); Laplace: Grant/Research Support (Ongoing); medtronic.: Grant/Research Support (Ongoing); trisol: Grant/Research Support (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)